{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T10:14:13Z","timestamp":1760609653536,"version":"build-2065373602"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejinme.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Internal Medicine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.ejim.2020.01.006","type":"journal-article","created":{"date-parts":[[2020,1,21]],"date-time":"2020-01-21T18:16:46Z","timestamp":1579630606000},"page":"50-54","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Impact of HCV eradication with direct-acting antiviral agents on serum gamma globulin levels in HCV and HCV\/HIV coinfected patients"],"prefix":"10.1016","volume":"75","author":[{"given":"Laura","family":"Milazzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorena","family":"van den Bogaart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salvatore","family":"Sollima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Letizia","family":"Oreni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Lai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Morena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cecilia","family":"Bonazzetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa","family":"Ridolfo Anna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spinello","family":"Antinori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejim.2020.01.006_bib0001","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jhep.2010.10.016","article-title":"Enhanced B-cell differentiation and reduced proliferative capacity in chronic hepatitis C and chronic hepatitis B virus infections","volume":"55","author":"Oliviero","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2020.01.006_bib0002","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1002\/hep.25821","article-title":"B cell homeostasis in chronic hepatitis C virus-related mixed cryoglobulinemia is maintained through na\u0131ve B cell apoptosis","volume":"56","author":"Holz","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2020.01.006_bib0003","doi-asserted-by":"crossref","first-page":"e68308","DOI":"10.1371\/journal.pone.0068308","article-title":"Enhanced activation of memory, but not na\u0131ve, B cells in chronic hepatitis C virus-infected patients with cryoglobulinemia and advanced liver fibrosis","volume":"8","author":"Santer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2020.01.006_bib0004","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/829584","article-title":"Emergence of exhausted B cells in asymptomatic HIV-1-infected patients naive for HAART is related to reduced immune surveillance","volume":"2012","author":"Fogli","year":"2012","journal-title":"Clin Dev Immunol"},{"issue":"Suppl 3","key":"10.1016\/j.ejim.2020.01.006_bib0005","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.ijid.2009.10.007","article-title":"Effect of combination antiretroviral treatment on total protein and calculated globulin levels among HIV-infected patients","volume":"14","author":"Serpa","year":"2010","journal-title":"Int J Infect Dis"},{"key":"10.1016\/j.ejim.2020.01.006_bib0006","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/jvh.12336","article-title":"Skewed B cells in chronic hepatitis C virus infection maintain their ability to respond to virus-induced activation","volume":"22","author":"Oliviero","year":"2015","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejim.2020.01.006_bib0007","doi-asserted-by":"crossref","first-page":"18544","DOI":"10.1073\/pnas.0509402102","article-title":"Activation of na\u0131ve B lymphocytes via CD81, a pathogenetic mechanism for hepatitis C virus associated B lymphocyte disorders","volume":"102","author":"Rosa","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ejim.2020.01.006_bib0008","doi-asserted-by":"crossref","first-page":"3745","DOI":"10.1182\/blood.V98.13.3745","article-title":"The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis","volume":"98","author":"Quinn","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.ejim.2020.01.006_bib0009","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1111\/jvh.12746","article-title":"Polyclonal and monoclonal B lymphocytes response in HCV-infected patients treated with direct-acting antiviral agents","volume":"24","author":"Schiavinato","year":"2017","journal-title":"J Viral Hepat"},{"key":"10.1016\/j.ejim.2020.01.006_bib0010","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/762709","article-title":"The expression of TLR-9, CD86, and CD95 phenotypes in circulating B cells of patients with chronic viral hepatitis B or C before and after antiviral therapy","volume":"2015","author":"Zhao","year":"2015","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.ejim.2020.01.006_bib0011","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/hep.1840210644","article-title":"Increased serum immunoglobulin G1 levels in hepatitis C virus infection","volume":"21","author":"Musset","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.ejim.2020.01.006_bib0012","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1097\/00000441-200303000-00006","article-title":"Extrahepatic manifestations of hepatitis C infection","volume":"325","author":"Mayo","year":"2003","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.ejim.2020.01.006_bib0013","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.jhep.2013.03.018","article-title":"Hepatitis C-associated B-cell non Hodgkin lymphomas. Epidemiology, molecular signature and clinical management","volume":"59","author":"Peveling-Oberhag","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/j.ejim.2020.01.006_bib0014","doi-asserted-by":"crossref","first-page":"745\u201052","DOI":"10.1111\/j.1349-7006.2004.tb03256.x","article-title":"Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies","volume":"95","author":"Matsuo","year":"2004","journal-title":"Cancer Sci"},{"issue":"8","key":"10.1016\/j.ejim.2020.01.006_bib0015","doi-asserted-by":"crossref","first-page":"107","DOI":"10.4254\/wjh.v8.i2.107","article-title":"Hepatitis C virus and non-Hodgkin's lymphomas: meta-analysis of epidemiology data and therapy options","volume":"18","author":"Pozzato","year":"2016","journal-title":"World J Hepatol"},{"key":"10.1016\/j.ejim.2020.01.006_bib0016","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1046\/j.1365-2249.2000.01396.x","article-title":"Hepatitis C virus (HCV) in lymphocyte subsets and in B lymphocytes expressing rheumatoid factor cross-reacting idiotype in type II mixed cryoglobulinaemia","volume":"122","author":"Fornasieri","year":"2000","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.ejim.2020.01.006_bib0017","article-title":"The injured liver induces hyperimmunoglobulinemia by failing to dispose of antigens and endotoxins in the portal system","volume":"10","author":"Liu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ejim.2020.01.006_bib0018","first-page":"486","article-title":"Bacterial translocation markers in liver cirrhosis","volume":"30","author":"Alexopoulou","year":"2017","journal-title":"Ann Gastroenterol"},{"key":"10.1016\/j.ejim.2020.01.006_bib0019","first-page":"493","article-title":"Serum immunoglobulins in patients with chronic hepatitis C: a surrogate marker of disease severity and treatment outcome","volume":"54","author":"Maruyama","year":"2007","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/j.ejim.2020.01.006_bib0020","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00126334-200212150-00003","article-title":"Effect of long-term highly active antiretroviral therapy in restoring HIV-induced abnormal B lymphocyte function","volume":"31","author":"Jacobson","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/j.ejim.2020.01.006_bib0021","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1111\/j.1468-1293.2005.00312.x","article-title":"The effect of combination antiretroviral therapy on CD5 B-cells, B-cell activation and hypergammaglobulinaemia in HIV-1-infected patients","volume":"6","author":"Redgrave","year":"2005","journal-title":"HIV Med"}],"container-title":["European Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520300066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0953620520300066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T09:32:38Z","timestamp":1760607158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0953620520300066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":21,"alternative-id":["S0953620520300066"],"URL":"https:\/\/doi.org\/10.1016\/j.ejim.2020.01.006","relation":{},"ISSN":["0953-6205"],"issn-type":[{"type":"print","value":"0953-6205"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of HCV eradication with direct-acting antiviral agents on serum gamma globulin levels in HCV and HCV\/HIV coinfected patients","name":"articletitle","label":"Article Title"},{"value":"European Journal of Internal Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejim.2020.01.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}